BridgeMD
New treatment option for Anaerobic Performance
Official title Pre-Sleep Creatine Enhances Anaerobic Power in Recreationally Active Females
ClinicalTrials.gov ID: NCT06937190
What this study is testing
- What it's testing
- This study is a randomized, double-blind, placebo-controlled trial designed to examine the effects of pre-sleep creatine monohydrate supplementation on anaerobic performance and muscle damage markers in recreationally active females. Participants will be randomly assigned to receive either 5 grams of creatine monohydrate or a placebo 30 minutes before sleep for seven consecutive days.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 25, women only. Healthy volunteers may be eligible.
You may be able to join if
- Female, aged 18 to 25 years
- Recreationally active (engaging in structured resistance training 3-4 times per week for the past 6 months)
- Regular menstrual cycles (used for scheduling purposes)
- Able and willing to provide informed consent
- Agreement to maintain normal diet and training routines throughout the study
You likely can't join if
- History of musculoskeletal injury affecting lower or upper limbs within the past 6 months
- Known allergy or intolerance to creatine or maltodextrin
- Use of performance-enhancing substances or supplements within the last 30 days
- Use of recovery modalities such as massage, cryotherapy, or compression garments during the study period
- Current use of anti-inflammatory medication
- Pregnancy or breastfeeding
See the full eligibility criteria
- Female, aged 18 to 25 years
- Recreationally active (engaging in structured resistance training 3-4 times per week for the past 6 months)
- Regular menstrual cycles (used for scheduling purposes)
- Able and willing to provide informed consent
- Agreement to maintain normal diet and training routines throughout the study
- History of musculoskeletal injury affecting lower or upper limbs within the past 6 months
- Known allergy or intolerance to creatine or maltodextrin
- Use of performance-enhancing substances or supplements within the last 30 days
- Use of recovery modalities such as massage, cryotherapy, or compression garments during the study period
- Current use of anti-inflammatory medication
- Pregnancy or breastfeeding
- Inability to comply with study protocol or scheduled assessments
The study team makes the final eligibility decision.
Where it's taking place
- Shabestar, East Azerbaijan Province, Iran
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 25 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shabestar, East Azerbaijan Province, Iran. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.